alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
##### 



CERTIFICATION PURSUANT TO
  1.
    
    I have reviewed this report on Form 10-Q for the quarterly period ended September 30, 2006 of
Belden & Blake Corporation;2.
    
    Based on my knowledge, this report does not contain any untrue statement of a material fact
or omit to state a material fact necessary to make the statements made, in light of the
circumstances under which such statements were made, not misleading with respect to the period
covered by this report;3.
    
    Based on my knowledge, the financial statements, and other financial information included in
this report, fairly present in all material respects the financial condition, results of
operations and cash flows of the registrant as of, and for, the periods presented in this
report;4.
    
    The registrants other certifying officer and I are responsible for establishing and
maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and
15d-15(e)), for the registrant and have:
    5.
    
    The registrants other certifying officer and I have disclosed, based on our most recent
evaluation of internal control over financial reporting, to the registrants auditors and the
audit committee of the registrants board of directors (or persons performing the equivalent
functions):
   Date: November 13, 2006
    By:

/s/
James M. VanderhiderJames M. Vanderhider, President and Chief Financial Officer
Breadcrumb

1. Hogar

2. Print 

3. Pdf 

4. Node 

5. Entity Print 

Livestock and Poultry Disease

Last Modified: 

Print

We protect against diseases that could harm the health, quality, or marketability of

our Nation's agricultural animals. With a vast network of partners, our Veterinary

Services team helps U.S. producers prevent, control, and when possible, eliminate

these diseases from our country.

APHIS also conducts surveillance and research on diseases and pathogens of

concern in wildlife. Visit our National Wildlife Disease Program and National Wildlife

Research Center to learn more.

Aquaculture 

Birds and Poultry 
Cattle and Bison 

Farmed Cervids 

Equine 

Sheep and Goats 

Swine 
Browse by animal disease (A-Z):

African horse sickness

African swine fever 

Asian longhorned tick

Avian influenza

Bluetongue

Bovine brucellosis

Bovine leukemia virus

Bovine spongiform encephalopathy

Bovine tuberculosis in cattle

Bovine tuberculosis in cervids

Cattle fever tick

Chronic wasting disease

Classical swine fever

Contagious equine metritis

Equine herpesvirus

Equine infectious anemia

Equine piroplasmosis

Equine viral arteritis

Exotic ticks and flies

Foot-and-mouth disease

Infectious salmon anemia

Johne's Disease

Mycoplasma ovipneumoniae

New World screwworm

Pseudorabies

Rabbit hemorrhagic disease

Scrapie

Spring viremia of carp
Swine brucellosis

Swine influenza

Tilapia lake virus

Trichomoniasis

Vector-borne equine encephalitides 

Vesicular stomatitis

Viral hemorrhagic septicemia virus

Virulent Newcastle disease

Ver mas Ver Menos

Animal Disease Services and Activities

Animal Health Studies (NAHMS) 

Animal Health Surveillance System (NAHSS) 

Center for Epidemiology and Animal Health (CEAH) 

Emergency Management 

Funding Opportunities 

Laboratory Information 

National List of Reportable Animal Diseases 

One Health 

Producer Indemnity and Compensation 

Status of Current Eradication Programs 

Traceability 

Veterinary Biologics 

Latest Updates

4/02/24

USDA Confirms Highly Pathogenic Avian Influenza in Dairy Herd in Idaho

4/01/24

USDA Confirms Highly Pathogenic Avian Influenza in Dairy Herd in New Mexico

3/20/24

USDA Confirms Highly Pathogenic Avian Influenza in Backyard Non-Poultry Flock in

West Virginia

3/01/24

Avian Metapneumovirus Update

2/26/24
APHIS Bolsters Animal Health Surveillance with Funding for Unexplained Morbidity or

Mortality Investigations

View All Updates
```

[Congressional Bills 114th Congress]
[From the U.S. Government Publishing Office]
[H. Res. 689 Introduced in House (IH)]

<DOC>

114th CONGRESS
  2d Session
H. RES. 689

    Expressing condolences to and support for the people of Ecuador 
        following the devastating earthquake on April 16, 2016.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                             April 18, 2016

   Mr. Crowley (for himself and Mr. Donovan) submitted the following 
   resolution; which was referred to the Committee on Foreign Affairs

_______________________________________________________________________

                               RESOLUTION

 
    Expressing condolences to and support for the people of Ecuador 
        following the devastating earthquake on April 16, 2016.

Whereas, on April 16, 2016, a 7.8 magnitude earthquake struck Ecuador that was 
        felt in neighboring countries;
Whereas the epicenter was 17 miles southeast of Muisne, according to the United 
        States Geological Survey;
Whereas the death toll has already exceeded 350, and authorities indicate that 
        thousands of Ecuadorians have gone missing;
Whereas the earthquake damaged or destroyed homes, hospitals, roads, and 
        businesses;
Whereas the United Nations indicates that tens of thousands of people are 
        sheltering in evacuation centers;
Whereas the earthquake has knocked out electricity and water to multiple 
        communities;
Whereas United States Secretary of State John Kerry indicated that ``we stand by 
        the people of Ecuador in this difficult time and are ready to assist in 
        any way we can.'';
Whereas according to the United States Census Bureau approximately 700,000 
        Ecuadorian-Americans reside in the United States;
Whereas the Ecuadorian-American community is deeply concerned about their 
        families, friends, and loved ones and are reaching out to assist in 
        recovery efforts; and
Whereas flooding from El Nino is creating additional challenges to search, 
        rescue, and recovery: Now, therefore, be it
    Resolved, That the House of Representatives--
            (1) expresses its sorrow and condolences on the loss of 
        life following the earthquake in Ecuador on April 16, 2016;
            (2) recognizes and commends all those engaged in the 
        domestic and international response to the earthquake in 
        Ecuador, including international agencies, the United States 
        Government, and nongovernment organizations; and
            (3) supports efforts by the United States Government to 
        assist the people of Ecuador as they seek to recover from the 
        earthquake.
                                 <all>
```
# C_2018436EN.01002001.xml

| 3.12.2018 | EN | Official Journal of the European Union | C 436/20 |
| --- | --- | --- | --- |

3.12.2018

EN

Official Journal of the European Union

C 436/20

---

Request for a preliminary ruling from the Bundesgerichtshof (Germany) lodged on 21 August 2018 — AS v Deutsches Patent- und Markenamt

(Case C-541/18)

(2018/C 436/25)

Language of the case: German

Referring court

Bundesgerichtshof

Parties to the main proceedings

Applicant: AS

Defendant: Deutsches Patent- und Markenamt

Question referred

Does a sign have distinctive character when there are in practice significant and obvious possibilities for it to be used as an indication of origin in respect of goods or services, even if this is not the most likely form of use of the sign? (1)

---

(1)  Interpretation of Article 3(1)(b) of Directive 2008/95/EC of the European Parliament and of the Council of 22 October 2008 to approximate the laws of the Member States relating to trade marks (OJ 2008 L 299, p. 25).

---
EXHIBIT 32.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER

PURSUANT TO

18 U.S.C. SECTION 1350,

AS
ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

I, Jimmy S.M. Lee, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the
Annual Report of Integrated Silicon Solution, Inc. on Form 10-K for the annual period ended September 30, 2007 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that the information
contained in such Annual Report on Form 10-K fairly presents in all material respects the financial condition and results of operations of Integrated Silicon Solution, Inc. as of and for the periods presented in such Annual Report on Form 10-K.



By:

/s/    Jimmy S.M. LeeJimmy S.M. LeeChairman of the Board and Chief ExecutiveOfficerDecember 14, 2007


I, Scott D. Howarth, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant
to Section 906 of the Sarbanes-Oxley Act of 2002, that the Annual Report of Integrated Silicon Solution, Inc. on Form 10-K for the annual period ended September 30, 2007 fully complies with the requirements of Section 13(a) or 15(d)
of the Securities Exchange Act of 1934 and that the information contained in such Annual Report on Form 10-K fairly presents in all material respects the financial condition and results of operations of Integrated Silicon Solution, Inc. as of and
for the periods presented in such Annual Report on Form 10-K.



By:

/s/    Scott D. HowarthScott D. HowarthPresident and Chief Financial OfficerDecember 14, 2007
EXHIBIT 99.3

                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

     In connection  with the Annual Report of Fonix  Corporation  on Form 10-K/A
(Amendment  No. 1) for the period  ending  December 31, 2001,  as filed with the
Securities and Exchange Commission on the date hereof (the "Report"),  I, Thomas
A.  Murdock,  Chief  Executive  Officer and  President of the Company,  certify,
pursuant to 18 U.S.C.  Section 1350,  as adopted  pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, that:

(1)  The Report fully complies with the  requirements  of section 13(a) or 15(d)
     of the Securities Exchange Act of 1934; and

(2)  The information  contained in the Report fairly  presents,  in all material
     respects, the financial condition and result of operations of the Company.


                                /s/ Thomas A. Murdock
                             ----------------------------------------------
                             Thomas A. Murdock
                             Chief Executive Officer and President
                             Fonix Corporation
                             December 13, 2002



<PAGE>







                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

     In connection  with the Annual Report of Fonix  Corporation  on Form 10-K/A
(Amendment  No. 1) for the period  ending  December 31, 2001,  as filed with the
Securities and Exchange  Commission on the date hereof (the "Report"),  I, Roger
D. Dudley,  Executive Vice President and Chief Financial Officer of the Company,
certify,  pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906
of the Sarbanes-Oxley Act of 2002, that:

(1)  The Report fully complies with the  requirements  of section 13(a) or 15(d)
     of the Securities Exchange Act of 1934; and

(2)  The information  contained in the Report fairly  presents,  in all material
     respects, the financial condition and result of operations of the Company.


                                /s/ Roger D. Dudley
                            ---------------------------------------------------
                            Roger D. Dudley
                            Executive Vice President,
                            Chief Financial Officer
                            Fonix Corporation
                            December 13, 2002
EXHIBIT 99


Office of Chief Accountant
Securities and Exchange Commission
450 Fifth Street, N.W.
Washington, D.C., 20549

March 27, 2002

Dear Sir or Madam,

Arthur Andersen LLP has represented to Fonix Corporation that the audit
completed for the year ended December 31, 2001 was subject to Arthur Andersen
LLP's quality control system for the United States accounting and auditing
practice. Arthur Andersen LLP has provided assurance to Fonix Corporation that
the audit engagement was conducted in compliance with professional standards.
The audit was conducted with the appropriate continuity and availability of
personnel, both in the United States and at the Company's foreign affiliate, as
well as the appropriate availability of national office consultation.


Sincerely,


/s/ Roger D. Dudley
--------------------------
Roger D. Dudley
Executive Vice President
Chief Financial Officer
# C_2022128EN.01001601.xml

| 21.3.2022 | EN | Official Journal of the European Union | C 128/16 |
| --- | --- | --- | --- |

21.3.2022

EN

Official Journal of the European Union

C 128/16

---

Judgment of the General Court of 9 February 2022 — Taminco and Arysta LifeScience Great Britain v Commission

(Case T-740/18) (1)

(Plant protection products - Active substance thiram - Non-renewal of approval - Regulation No 1107/2009 and Implementing Regulation No 844/2012 - Rights of the defence - Procedural irregularity - Manifest error of assessment - Competence of EFSA - Proportionality - Precautionary principle - Equal treatment)

(2022/C 128/21)

Language of the case: English

Parties

Applicants: Taminco BVBA (Ghent, Belgium), Arysta LifeScience Great Britain Ltd (Edinburgh, United Kingdom) (represented by: C. Mereu and M. Grunchard, lawyers)

Defendant: European Commission (represented by: G. Koleva, acting as Agent)

Re:

APPLICATION under Article 263 TFEU for annulment of Commission Implementing Regulation (EU) 2018/1500 of 9 October 2018 concerning the non-renewal of approval of the active substance thiram, and prohibiting the use and sale of seeds treated with plant protection products containing thiram, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending Commission Implementing Regulation (EU) No 540/2011 (OJ 2018 L 254, p. 1).

Operative part of the judgment

The Court:

| 1. | Dismisses the action; |
| --- | --- |

1.

Dismisses the action;

| 2. | Orders Taminco BVBA and Arysta LifeScience Great Britain Ltd to bear their own costs and those incurred by the European Commission in the context of the present action; |
| --- | --- |

2.

Orders Taminco BVBA and Arysta LifeScience Great Britain Ltd to bear their own costs and those incurred by the European Commission in the context of the present action;

| 3. | Orders Taminco to bear its own costs and those incurred by the Commission in the context of the proceedings for interim measures. |
| --- | --- |

3.

Orders Taminco to bear its own costs and those incurred by the Commission in the context of the proceedings for interim measures.

---

(1)  OJ C 72, 25.2.2019.

---
# C_2018455EN.01002001.xml

| 17.12.2018 | EN | Official Journal of the European Union | C 455/20 |
| --- | --- | --- | --- |

17.12.2018

EN

Official Journal of the European Union

C 455/20

---

Appeal brought on 10 September 2018 by HF against the judgment of the General Court (First Chamber, Extended Composition) delivered on 29 June 2018 in Case T-218/17, HF v Parliament

(Case C-570/18 P)

(2018/C 455/29)

Language of the case: French

Parties

Appellant: HF (represented by: A. Tymen, avocate)

Other party to the proceedings: European Parliament

Form of order sought

The appellant claims that the Court should:

| — | set aside the judgment of the General Court of 29 June 2018 in Case T-218/17,
  Consequently, |
| --- | --- |

—

set aside the judgment of the General Court of 29 June 2018 in Case T-218/17,

Consequently,

| — | uphold the form of order sought by the appellant at first instance and, thus, |
| --- | --- |

—

uphold the form of order sought by the appellant at first instance and, thus,

| — | annul the decision of the European Parliament of 30 June 2016 rejecting the appellant’s request for assistance, |
| --- | --- |

—

annul the decision of the European Parliament of 30 June 2016 rejecting the appellant’s request for assistance,

| — | order the Parliament to pay compensation in respect of non-financial harm estimated ex aequo et bono at EUR 90 000, |
| --- | --- |

—

order the Parliament to pay compensation in respect of non-financial harm estimated ex aequo et bono at EUR 90 000,

| — | order the European Parliament to pay all of the costs incurred at first instance and on appeal. |
| --- | --- |

—

order the European Parliament to pay all of the costs incurred at first instance and on appeal.

Grounds of appeal and main arguments

| — | Breach of the right to be heard — Breach of Article 41[(2)](a) of the Charter; |
| --- | --- |

—

Breach of the right to be heard — Breach of Article 41[(2)](a) of the Charter;

| — | Breach of Article 41(1) of the Charter — Distortion of the arguments of the appellant — Breach by the General Court of its obligation to state reasons; |
| --- | --- |

—

Breach of Article 41(1) of the Charter — Distortion of the arguments of the appellant — Breach by the General Court of its obligation to state reasons;

| — | Breach of Article 31(1) of the Charter — Infringement of Article 12a(1), (3) and (24) of the Staff Regulations. |
| --- | --- |

—

Breach of Article 31(1) of the Charter — Infringement of Article 12a(1), (3) and (24) of the Staff Regulations.

Furthermore, the appellant disputes the decision of the General Court to reject her claim for damages on the ground that the contested decision has not been set aside.

---
<PAGE>

EXHIBIT 32.2 - CFO 906 CERTIFICATION

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED PURSUANT TO SECTION
                      906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report of Interland, Inc. (the "Company") on Form
10-K for the period ending August 31, 2004 as filed with the Securities and
Exchange Commission on the date hereof (the "Report"), I, Allen L. Shulman,
Chief Financial Officer, certify, pursuant to 18 U.S.C. Section 1350, as adopted
pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of
my knowledge:

1.       The Report fully complies with the requirements of Section 13(a) of the
         Securities Exchange Act of 1934; and

2.       The information contained in the Report fairly presents, in all
         material respects, the financial condition and results of operations of
         the Company.

Date: November 15, 2004


                            /s/ Allen L. Shulman
                            -----------------------------------------------
                            Allen L. Shulman
                            Senior Vice President, Chief Financial Officer, and
                            Senior Counsel
**USA COMMENTS**

**THE USE OF ENVIRONMENTAL DNA METHODS FOR DETECTION OFOIE LISTED AQUATIC ANIMAL DISEASES**

﻿A discussion paper developed by the OIE Aquatic Animal Health Standards Commission (Aquatic Animals Commission) for Member comments.

Version: 6 May 2021 

...

9. **Potential application of eDNA detection methods in the disease-specific chapters of the *Aquatic Manual***

The disease-specific chapters**of the*Aquatic Manual* recommend tests to identify suspect cases and to confirm suspicion for apparently healthy (or those of unknown health status) and clinically affected animals. Apparently healthy populations may fall under suspicion, and therefore be sampled, if there is an epidemiological link(s) to an infected population. Geographic proximity to, or movement of aquatic animals or aquatic animal products or equipment, etc., from a known infected population equate to an epidemiological link. Alternatively, healthy populations are sampled in surveys to demonstrate freedom. 

The following points describe the suitability of evidence from eDNA detection methods for inclusion as case definition criteria in section 6 of the disease-specific chapters of the *Aquatic Manual.*

**a)	Apparently healthy animals**

**i)	Definition of suspect case in a population of apparently healthy animals**

*Suitable as a criterion*. A positive result obtained from an eDNA method recommended in the *Aquatic Manual* is considered to provide adequate evidence to be included as a criterion for a suspect case when known susceptible species exist in the same aquatic environment.

**Rationale:** Include “when known susceptible species exist in the same aquatic environment” to this definition. It is important that a case is only consider suspect if there are actually animals present to substantiate a positive finding. If not, suspect cases could be made based on a solely on an eDNA finding.
#### The State, ex rel. Joseph, *v.*Crossland, Judge.

(No. 31853

Decided October 26, 1949.)

*200
      *Mr. Jo.seph L. Meencm*and *Mr. Paul M. Herbert,*for relator.

*Mr. C. Alfred Zinn, Mr. J. Lincoln Knapp*and *Mr. Donald P. Jones,*for respondent.

By the Court.

Counsel for relator contend that a disbarment proceeding is penal in nature, having all the attributes of a criminal case, and is to be governed by the laws of criminal practice in a special statutory proceeding or quasi-criminal case and not in an ordinary civil case. They contend further that the latter portion of Section 1708, General Code, relating to disbarment and reading, “he shall be allowed a reasonable time to collect and present testimony in defense, and he shall be heard by himself or counsel,” and the requirements of Section 13442-1, General Code, *201that “criminal cases shall be given precedence over civil matters” and “shall be forthwith set for trial within a reasonable time, not exceeding thirty days thereafter,” are mandatory.

The above-quoted provisions of Section 1708, General Code, are mandatory, but they do not deal with fixing the time for hearing a disbarment proceeding.

Counsel relying on Section 13442-1, General Code, maintain that since statutes relating to disbarment are penal in nature, they are to be strictly construed. The requirements of disbarment statutes are to be strictly construed in favor of one against whom charges are filed, but the fact that the court may reprimand, suspend or disbar an attorney does not convert a disbarment proceeding into a criminal prosecution to be tried pursuant to the Criminal Code of this state.

Section 11385, among other sections of the General Code, specifies those civil cases which are to be 'given preference in assignment for trial and gives discretion to the court in directing the order in which other cases are to be heard. There is no allegation that this, disbarment proceeding will not be heard in its regular order.

The writ of mandamus will not issue to control the exercise of discretion. The pleaded facts do not allege a clear abuse of discretion.

The writ will issue to command the performance of an act which the law specially enjoins as a duty. Section 12283, General Code. No such duty has been alleged by relator.

The demurrer is sustained and a writ denied.

*Writ denied.*

Weygandt, C. J., Hart, Zimmerman and Turner, JJ., concur.
Bureau of Labor Statistics

Series Id:

Series title:

Labor force status:

Type of data:

Age:

Years:

Year Qtr1 Qtr2 Qtr3 Qtr4 Annual

2011 45507

Not in labor force

Number in thousands

55 years and over

2011 to 2011

Labor Force Statistics from the Current Population Survey

Original Data Value

LNU05024230Q

Not Seasonally Adjusted

(Unadj) Not in Labor Force, 55 yrs. & over

Source: Bureau of Labor Statistics Generated on: May 16, 2011 (02:09:51 PM)